Microplastic Will Test EU’s Green Tenacity As Cosmetics Regulatory Revision Looms
Where the European Commission and Member States land in their final deliberations on the proposed microplastic ban could reveal a lot about industry costs deemed acceptable and the level of science considered necessary to regulate cosmetics and other markets in pursuance of Green Deal objectives.
You may also be interested in...
To cosmetics industry stakeholders, the EU’s talk of instituting a generic risk management approach to eliminate “most hazardous” chemicals spells wholesale adoption of the precautionary principle, the disposal of exposure and risk considerations, and, ultimately, increased cosmetic ingredient restrictions and bans without proportionate human health benefits.
Formed by the FDA in fall 2018 and convened in early 2020 for a public meeting, the Interagency Working Group on Asbestos in Consumer Products maintains that electron microscopy should be a first-line method for detecting asbestos in cosmetic talc and talc-containing products, and that labs should report elongate mineral particles beyond those classically understood as asbestos.
The FDA offers insight into possible sources of benzene contamination in drug products, including aerosol spray propellants, carbomers, or other drug components made from hydrocarbons. Manufacturers that find benzene in drug product batches at levels exceeding 2 ppm should not release the product or, if already in distribution, discuss with the FDA initiating a voluntary recall.